MEDTECH TWENTE BUILDING BLOCKS
MedTech Innovations & Reimbursements: Perspectives of a Health Insurer, the National Health Care Institute and patients
How do you ensure the care provider and patient accept a medical technology innovation and the health insurer reimburses the new technology? To do this, it is essential to understand how these parties view new medical technology. During this session, we will get a glimpse into the world of MedTech innovations and reimbursement, as seen from (1) the health insurer, (2) the National Health Care Institute, and (3) the patient.
Developers of MedTech innovations often have to deal with health insurers, the National Health Care Institute, and patient organizations to successfully bring their products to market. Financing and reimbursement depend on what type of innovation is involved, which system law it falls under, and the role of various parties involved in these various routes.
- Health insurance companies are vital links in the reimbursement process for innovations, which is essential for the financial feasibility and acceptance of new technologies.
- National Health Care Institute is a government organization whose main task is to compile the basic health insurance package, including making assessments and issuing advice to the Ministry of Health, Welfare, and Sport.
- Patient organizations, with their invaluable insights into patients’ needs and experiences, play a crucial role in the development of products that truly enhance patient care, thereby increasing the likelihood of successful adoption and reimbursement.
We have invited three parties to give a ‘look behind the scenes’: a major Dutch insurer (to follow soon!), patient organization ReumaNederland and the National Health Care Institute.
This session is essential for anyone involved in medical technology innovations who wants to understand how reimbursement processes work. The goal is to shed more light on these organizations’ crucial roles in reimbursing MedTech innovations.
REGISTER
What: MedTech Twente knowledge session
Date: Tuesday, September 17
Time: 8:45 – 13:00 hrs (including lunch)
Location: DesignLab, University of Twente
Language: Dutch
Sign up: https://share.hsforms.com/1mbkfYiJhTqK_SzDirEIZuw2gf1i
PROGRAM
8:45 – 9:00 | Walk in with coffee and tea
9:00 – 9:10 | Welcome by innovation cluster MedTech Twente
9:10 – 10:10 | Innovation specialist Dutch health insurer (to follow)
10:10 – 10:25 | Break
10:25 – 11:25 | Corné Baatenburg de Jong – Deputy Director at Reuma Netherlands
ReumaNederland is a patient organization focused on improving the quality of life for people with rheumatic diseases through education, advocacy, and scientific research. In recent years, Corné has had the opportunity to experience, guide, and realize many projects and implementation processes from close up, thereby examining all mutual interests, including those from the patients’ perspective.
11:25 – 12:25 | Robin Toorneman – Senior Advisor Healthcare Innovations at National Health Care Institute
The National Health Care Institute plays a central role in the Dutch healthcare system by advising on the basic health insurance package, developing guidelines, and assessing new medical technologies for effectiveness and safety. Together, they form the core of the discussion on the future of Medtech innovations and the role of reimbursement in healthcare.
12:25-12:30 | Closing
Until approximately 13:15 | Networking lunch